You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
Merck
Baxter
Colorcon

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,324,157


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,324,157
Title:Preparation comprising insulin, nicotinamide and an amino acid
Abstract: Insulin preparations comprising an insulin compound or a mixture of two or more insulin compounds, a nicotinic compound and an amino acid.
Inventor(s): Olsen; Helle Birk (Bagsv.ae butted.rd, DK), Havelund; Svend (Bagsv.ae butted.rd, DK), Ribel-Madsen; Ulla (Bagsv.ae butted.rd, DK), Sturis; Jeppe (Bagsv.ae butted.rd, DK), Naver; Helle (Bagsv.ae butted.rd, DK), Schlein; Morten (Bagsv.ae butted.rd, DK), Ludvigsen; Svend (Bagsv.ae butted.rd, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:13/309,134
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 8,324,157

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo FIASP insulin aspart SOLUTION;INTRAVENOUS, SUBCUTANEOUS 208751-001 Sep 29, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Novo FIASP FLEXTOUCH insulin aspart SOLUTION;SUBCUTANEOUS 208751-002 Sep 29, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,324,157

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
09163940Jun 26, 2009

International Family Members for US Patent 8,324,157

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010264636   Start Trial
Brazil PI1014760   Start Trial
Canada 2764423   Start Trial
China 102470165   Start Trial
China 104667264   Start Trial
Denmark 2340033   Start Trial
Denmark 2612677   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.